BGM Group Announces Its Acquisition Of The Intelligent Platform Of AIX Inc. For ~$140M
BGM Group Announces Its Acquisition Of The Intelligent Platform Of AIX Inc. For ~$140M
BGM Group Ltd. (NASDAQ:BGM) ("the Company" or "BGM"), a leading global pharmaceutical enterprise, today announced its acquisition of the intelligent platform of AIX Inc. (NASDAQ:AIFU) ("AIX") valued at 1 billion RMB (approximately $140 million). The intelligent platform encompasses AIX's subsidiaries – RONS Intelligent Technology (Beijing) Co., Ltd. ("RONS Technology") and Shenzhen Xinbao Investment Management Co., Ltd. ("Xinbao Investment"). Completion of the transaction is anticipated by the end of 2024.
BGm集團有限公司(NASDAQ:BGM)（"公司"或"BGM"），一家領先的全球製藥企業，今天宣佈收購了AIX公司智能平台。AIX公司(NASDAQ:AIFU)（"AIX"）的智能平台價值10億人民幣（約14000萬美元）。該智能平台涵蓋了AIX的子公司-羅恩斯智能技術（北京）有限公司("羅恩斯科技") 和深圳新寶投資管理有限公司("新寶投資"). 預計交易將於2024年底前完成。
Through this strategic acquisition, BGM formally ventures into the domains of AI intelligent technology and financial and insurance services, setting the stage for diversified growth beyond biopharmaceuticals and inaugurating a new era for the Company in the digital and intelligent landscape.
通過這一戰略收購，BGm正式進軍人工智能科技和金融保險服務領域，爲超越生物製藥業務的多樣化增長奠定了基礎，並開創了公司在數字和智能領域的新時代。
譯文內容由第三人軟體翻譯。
